Cell-surface cascaded landing location for nanotheranostics

Abstract Theranostics is an appealing approach in precision medicine and it is still a critical challenge to design smart strategies which can precisely accumulate the functional probes/drugs into targeted disease areas. Cell-surface cascaded landing location is an effective strategy to develop functional drug-loading platforms to explore basic physiological processes at the cellular level and to facilitate the development of nanotheranostics for disease treatment.

[1]  X. Tong,et al.  Aptamer Functionalized Cisplatin-Albumin Nanoparticles for Targeted Delivery to Epidermal Growth Factor Receptor Positive Cervical Cancer. , 2016, Journal of biomedical nanotechnology.

[2]  M. Chougule,et al.  Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging. , 2015, Journal of biomedical nanotechnology.

[3]  Audrey Lee-Gosselin,et al.  Tunable thermal bioswitches for in vivo control of microbial therapeutics. , 2017, Nature chemical biology.

[4]  D. Parker,et al.  Critical design issues in the targeted molecular imaging of cell surface receptors. , 2015, Chemical Society reviews.

[5]  Z. Qian,et al.  Long-Acting Release Formulation of Exendin-4 Based on Biomimetic Mineralization for Type 2 Diabetes Therapy. , 2017, ACS nano.

[6]  C. Walsh.  Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[7]  P. Sorensen,et al.  Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein. , 2015, Cancer cell.

[8]  Gang Liu,et al.  Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging , 2016, International journal of nanomedicine.

[9]  Bing Xu,et al.  Dual Fluorescent- and Isotopic-Labelled Self-Assembling Vancomycin for in vivo Imaging of Bacterial Infections. , 2017, Angewandte Chemie.

[10]  Weihong Tan,et al.  DNA probes for monitoring dynamic and transient molecular encounters on live cell membranes. , 2017, Nature nanotechnology.

[11]  Z. Qian,et al.  Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging. , 2016, Journal of biomedical nanotechnology.

[12]  P. Low,et al.  Principles in the design of ligand-targeted cancer therapeutics and imaging agents , 2015, Nature Reviews Drug Discovery.

[13]  Gang Liu,et al.  Imaging-guided delivery of RNAi for anticancer treatment. , 2016, Advanced drug delivery reviews.

[14]  Jong Seung Kim,et al.  Small conjugate-based theranostic agents: an encouraging approach for cancer therapy. , 2015, Chemical Society reviews.